Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Imeglimin shows promise in phase II trials in type 2 diabetes

Sep. 29, 2010

Phase II data on MK-0941 cast doubt on suitability for treatment of diabetes

Sep. 29, 2010

Namisol tablet for multiple sclerosis shows promise in first-in-human trial

Sep. 28, 2010

E-6005 improves pruritus and inflammation in preclinical tests

Sep. 28, 2010

NexMed and Bio-Quant present preclinical data on PrevOnco

Sep. 28, 2010

Phico Therapeutics details phase I tolerability of PT1.2

Sep. 27, 2010

BI-10773 improves glycemic control in large study in type 2 diabetes

Sep. 27, 2010

Novartis reports on clinical development of LDE-225

Sep. 27, 2010

Interim phase I/II data suggest safety of everolimus in advanced HCC

Sep. 27, 2010

Phase I data presented on hypnotic agent GF-015535-00

Sep. 27, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 24, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...
In the clinic for June 22, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Alkermes, Boehringer, Cambrian, F2G, Intrabio, Lexeo, Memo, Novocure,...